Filed: 8/14/2025ACC: 0001315863-25-000627
📋 What this filing means
CRESTLINE MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $62.56M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$62.56M
Total AUM (reported)
7.27M
Total Shares
Allocation by class
COM$62.56M100.0%
Portfolio Concentration
Top 3$62.56M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 7.27M
Sole
Full voting authority
7.27M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
DENALI THERAPEUTICS INC
SOLEShares3.86M
TypeSH
Market value$54.01M
86.33%
Sole
3.86M
Shared
0.00
None
0.00
SANA BIOTECHNOLOGY INC
SOLEShares2.42M
TypeSH
Market value$6.61M
10.56%
Sole
2.42M
Shared
0.00
None
0.00
8X8 INC NEW
SOLEShares990.58K
TypeSH
Market value$1.94M
3.10%
Sole
990.58K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DENALI THERAPEUTICS INCSOLE | COM | 3.86M | SH | $54.01M 86.33% | 3.86M | 0.00 | 0.00 |
SANA BIOTECHNOLOGY INCSOLE | COM | 2.42M | SH | $6.61M 10.56% | 2.42M | 0.00 | 0.00 |
8X8 INC NEWSOLE | COM | 990.58K | SH | $1.94M 3.10% | 990.58K | 0.00 | 0.00 |